世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
アルツハイマー病非薬理学的治療装置の世界市場成長2024-2030年Global Alzheimer's Non-Pharmacological Treatment Device Market Growth 2024-2030 世界のアルツハイマー型非薬理学的治療装置市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は％と予測される。 LPインフォメーション社の... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリー世界のアルツハイマー型非薬理学的治療装置市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は％と予測される。LPインフォメーション社の最新調査レポート「アルツハイマー型非薬理学的治療装置産業予測」は、過去の販売実績と2023年のアルツハイマー型非薬理学的治療装置の世界総販売実績を調査し、2024年から2030年までのアルツハイマー型非薬理学的治療装置の予測販売実績を地域別・市場分野別に包括的に分析しています。アルツハイマー型非薬理学的治療装置の販売を地域別、市場分野別、サブセクター別に分類し、世界のアルツハイマー型非薬理学的治療装置産業の詳細な分析を百万米ドル単位で提供します。 本インサイトレポートでは、世界のアルツハイマー型非薬理学的治療デバイスの状況を包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また本レポートでは、アルツハイマー病非薬理学的治療デバイスのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、世界の主要企業の戦略を分析し、加速する世界のアルツハイマー病非薬理学的治療デバイス市場におけるこれらの企業の独自の地位をより良く理解しています。 本インサイトレポートでは、アルツハイマー病非薬理学的治療装置の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い方法論により、この調査予測は世界のアルツハイマー型非薬理学的治療装置の現状と将来の軌道について非常にニュアンスのある見解を提供します。 アルツハイマー病非薬理学的治療デバイスの米国市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は％と推定される。 アルツハイマー病非薬理学的治療デバイスの中国市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は％と推定される。 アルツハイマー病非薬理学的治療デバイスのヨーロッパ市場は、2023年の百万米ドルから2030年には百万米ドルに増加し、2024年から2030年までの年平均成長率は％と推定される。 世界の主要なアルツハイマー病非薬理学的治療装置のプレーヤーは、Magstim、NeuroConn、Abbott、Boston Scientific、Neuropaceなどをカバーしています。収益面では、世界の2大企業が2023年にほぼ％のシェアを占めている。 のシェアを占めています。 本レポートでは、アルツハイマー病非薬理学的治療装置市場の包括的な概要、市場シェア、成長機会を、製品タイプ、用途、主要メーカー、主要地域、国別に紹介します。 タイプ別セグメント 脳刺激装置 光・音響刺激装置 その他 用途別セグメント 病院 クリニック その他 本レポートは地域別にも市場を分割しています： 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 マグスティム ニューロコン アボット ボストン・サイエンティフィック ニューロスペース アレバ・ニューロセラピューティクス レイボリー エレクトロコア メドトロニック インターアクソン フィッシャー・ウォレス ドリーム シーンレイ ピンズメディカル スペクトリス 本レポートで扱う主な質問 世界のアルツハイマー病非薬理学的治療装置市場の10年展望は？ アルツハイマー病非薬理学的治療装置の世界市場および地域別市場成長を促進する要因は何か？ 市場別、地域別で最も急成長する技術は何か？ アルツハイマー病非薬理学的治療デバイスの市場機会は最終市場規模によってどのように異なるのか？ アルツハイマー病非薬理学的治療デバイスのタイプ別、用途別の内訳は？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Alzheimer's Non-Pharmacological Treatment Device by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Alzheimer's Non-Pharmacological Treatment Device by Country/Region, 2019, 2023 & 2030 2.2 Alzheimer's Non-Pharmacological Treatment Device Segment by Type 2.2.1 Brain Stimulation Device 2.2.2 Optical and Acoustic Stimulation Device 2.2.3 Others 2.3 Alzheimer's Non-Pharmacological Treatment Device Sales by Type 2.3.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Type (2019-2024) 2.3.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue and Market Share by Type (2019-2024) 2.3.3 Global Alzheimer's Non-Pharmacological Treatment Device Sale Price by Type (2019-2024) 2.4 Alzheimer's Non-Pharmacological Treatment Device Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Alzheimer's Non-Pharmacological Treatment Device Sales by Application 2.5.1 Global Alzheimer's Non-Pharmacological Treatment Device Sale Market Share by Application (2019-2024) 2.5.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue and Market Share by Application (2019-2024) 2.5.3 Global Alzheimer's Non-Pharmacological Treatment Device Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Alzheimer's Non-Pharmacological Treatment Device Breakdown Data by Company 3.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales by Company (2019-2024) 3.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Company (2019-2024) 3.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue by Company (2019-2024) 3.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Company (2019-2024) 3.2.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Company (2019-2024) 3.3 Global Alzheimer's Non-Pharmacological Treatment Device Sale Price by Company 3.4 Key Manufacturers Alzheimer's Non-Pharmacological Treatment Device Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Alzheimer's Non-Pharmacological Treatment Device Product Location Distribution 3.4.2 Players Alzheimer's Non-Pharmacological Treatment Device Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Alzheimer's Non-Pharmacological Treatment Device by Geographic Region 4.1 World Historic Alzheimer's Non-Pharmacological Treatment Device Market Size by Geographic Region (2019-2024) 4.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Alzheimer's Non-Pharmacological Treatment Device Market Size by Country/Region (2019-2024) 4.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales by Country/Region (2019-2024) 4.2.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue by Country/Region (2019-2024) 4.3 Americas Alzheimer's Non-Pharmacological Treatment Device Sales Growth 4.4 APAC Alzheimer's Non-Pharmacological Treatment Device Sales Growth 4.5 Europe Alzheimer's Non-Pharmacological Treatment Device Sales Growth 4.6 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales Growth 5 Americas 5.1 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Country 5.1.1 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2019-2024) 5.1.2 Americas Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2019-2024) 5.2 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 5.3 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Region 6.1.1 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Region (2019-2024) 6.1.2 APAC Alzheimer's Non-Pharmacological Treatment Device Revenue by Region (2019-2024) 6.2 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 6.3 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Alzheimer's Non-Pharmacological Treatment Device by Country 7.1.1 Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2019-2024) 7.1.2 Europe Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2019-2024) 7.2 Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 7.3 Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device by Country 8.1.1 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2019-2024) 8.1.2 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2019-2024) 8.2 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 8.3 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Alzheimer's Non-Pharmacological Treatment Device 10.3 Manufacturing Process Analysis of Alzheimer's Non-Pharmacological Treatment Device 10.4 Industry Chain Structure of Alzheimer's Non-Pharmacological Treatment Device 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Alzheimer's Non-Pharmacological Treatment Device Distributors 11.3 Alzheimer's Non-Pharmacological Treatment Device Customer 12 World Forecast Review for Alzheimer's Non-Pharmacological Treatment Device by Geographic Region 12.1 Global Alzheimer's Non-Pharmacological Treatment Device Market Size Forecast by Region 12.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Forecast by Region (2025-2030) 12.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Alzheimer's Non-Pharmacological Treatment Device Forecast by Type (2025-2030) 12.7 Global Alzheimer's Non-Pharmacological Treatment Device Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Magstim 13.1.1 Magstim Company Information 13.1.2 Magstim Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.1.3 Magstim Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Magstim Main Business Overview 13.1.5 Magstim Latest Developments 13.2 NeuroConn 13.2.1 NeuroConn Company Information 13.2.2 NeuroConn Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.2.3 NeuroConn Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 NeuroConn Main Business Overview 13.2.5 NeuroConn Latest Developments 13.3 Abbott 13.3.1 Abbott Company Information 13.3.2 Abbott Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.3.3 Abbott Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Abbott Main Business Overview 13.3.5 Abbott Latest Developments 13.4 Boston Scientific 13.4.1 Boston Scientific Company Information 13.4.2 Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.4.3 Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Boston Scientific Main Business Overview 13.4.5 Boston Scientific Latest Developments 13.5 Neuropace 13.5.1 Neuropace Company Information 13.5.2 Neuropace Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.5.3 Neuropace Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Neuropace Main Business Overview 13.5.5 Neuropace Latest Developments 13.6 Aleva Neurotherapeutics 13.6.1 Aleva Neurotherapeutics Company Information 13.6.2 Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.6.3 Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Aleva Neurotherapeutics Main Business Overview 13.6.5 Aleva Neurotherapeutics Latest Developments 13.7 Laborie 13.7.1 Laborie Company Information 13.7.2 Laborie Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.7.3 Laborie Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Laborie Main Business Overview 13.7.5 Laborie Latest Developments 13.8 Electrocore 13.8.1 Electrocore Company Information 13.8.2 Electrocore Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.8.3 Electrocore Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Electrocore Main Business Overview 13.8.5 Electrocore Latest Developments 13.9 Medtronic 13.9.1 Medtronic Company Information 13.9.2 Medtronic Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.9.3 Medtronic Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Medtronic Main Business Overview 13.9.5 Medtronic Latest Developments 13.10 Interaxon 13.10.1 Interaxon Company Information 13.10.2 Interaxon Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.10.3 Interaxon Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Interaxon Main Business Overview 13.10.5 Interaxon Latest Developments 13.11 Fisher Wallace 13.11.1 Fisher Wallace Company Information 13.11.2 Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.11.3 Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Fisher Wallace Main Business Overview 13.11.5 Fisher Wallace Latest Developments 13.12 Dreem 13.12.1 Dreem Company Information 13.12.2 Dreem Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.12.3 Dreem Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Dreem Main Business Overview 13.12.5 Dreem Latest Developments 13.13 SceneRay 13.13.1 SceneRay Company Information 13.13.2 SceneRay Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.13.3 SceneRay Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 SceneRay Main Business Overview 13.13.5 SceneRay Latest Developments 13.14 Pins Medical 13.14.1 Pins Medical Company Information 13.14.2 Pins Medical Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.14.3 Pins Medical Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Pins Medical Main Business Overview 13.14.5 Pins Medical Latest Developments 13.15 Spectris 13.15.1 Spectris Company Information 13.15.2 Spectris Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.15.3 Spectris Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 Spectris Main Business Overview 13.15.5 Spectris Latest Developments 14 Research Findings and Conclusion
SummaryThe global Alzheimer's Non-Pharmacological Treatment Device market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Alzheimer's Non-Pharmacological Treatment Device by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Alzheimer's Non-Pharmacological Treatment Device by Country/Region, 2019, 2023 & 2030 2.2 Alzheimer's Non-Pharmacological Treatment Device Segment by Type 2.2.1 Brain Stimulation Device 2.2.2 Optical and Acoustic Stimulation Device 2.2.3 Others 2.3 Alzheimer's Non-Pharmacological Treatment Device Sales by Type 2.3.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Type (2019-2024) 2.3.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue and Market Share by Type (2019-2024) 2.3.3 Global Alzheimer's Non-Pharmacological Treatment Device Sale Price by Type (2019-2024) 2.4 Alzheimer's Non-Pharmacological Treatment Device Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Alzheimer's Non-Pharmacological Treatment Device Sales by Application 2.5.1 Global Alzheimer's Non-Pharmacological Treatment Device Sale Market Share by Application (2019-2024) 2.5.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue and Market Share by Application (2019-2024) 2.5.3 Global Alzheimer's Non-Pharmacological Treatment Device Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Alzheimer's Non-Pharmacological Treatment Device Breakdown Data by Company 3.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales by Company (2019-2024) 3.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Company (2019-2024) 3.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue by Company (2019-2024) 3.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Company (2019-2024) 3.2.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Company (2019-2024) 3.3 Global Alzheimer's Non-Pharmacological Treatment Device Sale Price by Company 3.4 Key Manufacturers Alzheimer's Non-Pharmacological Treatment Device Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Alzheimer's Non-Pharmacological Treatment Device Product Location Distribution 3.4.2 Players Alzheimer's Non-Pharmacological Treatment Device Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Alzheimer's Non-Pharmacological Treatment Device by Geographic Region 4.1 World Historic Alzheimer's Non-Pharmacological Treatment Device Market Size by Geographic Region (2019-2024) 4.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Alzheimer's Non-Pharmacological Treatment Device Market Size by Country/Region (2019-2024) 4.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Annual Sales by Country/Region (2019-2024) 4.2.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue by Country/Region (2019-2024) 4.3 Americas Alzheimer's Non-Pharmacological Treatment Device Sales Growth 4.4 APAC Alzheimer's Non-Pharmacological Treatment Device Sales Growth 4.5 Europe Alzheimer's Non-Pharmacological Treatment Device Sales Growth 4.6 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales Growth 5 Americas 5.1 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Country 5.1.1 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2019-2024) 5.1.2 Americas Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2019-2024) 5.2 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 5.3 Americas Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Region 6.1.1 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Region (2019-2024) 6.1.2 APAC Alzheimer's Non-Pharmacological Treatment Device Revenue by Region (2019-2024) 6.2 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 6.3 APAC Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Alzheimer's Non-Pharmacological Treatment Device by Country 7.1.1 Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2019-2024) 7.1.2 Europe Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2019-2024) 7.2 Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 7.3 Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device by Country 8.1.1 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2019-2024) 8.1.2 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2019-2024) 8.2 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2019-2024) 8.3 Middle East & Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Alzheimer's Non-Pharmacological Treatment Device 10.3 Manufacturing Process Analysis of Alzheimer's Non-Pharmacological Treatment Device 10.4 Industry Chain Structure of Alzheimer's Non-Pharmacological Treatment Device 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Alzheimer's Non-Pharmacological Treatment Device Distributors 11.3 Alzheimer's Non-Pharmacological Treatment Device Customer 12 World Forecast Review for Alzheimer's Non-Pharmacological Treatment Device by Geographic Region 12.1 Global Alzheimer's Non-Pharmacological Treatment Device Market Size Forecast by Region 12.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Forecast by Region (2025-2030) 12.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Alzheimer's Non-Pharmacological Treatment Device Forecast by Type (2025-2030) 12.7 Global Alzheimer's Non-Pharmacological Treatment Device Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Magstim 13.1.1 Magstim Company Information 13.1.2 Magstim Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.1.3 Magstim Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Magstim Main Business Overview 13.1.5 Magstim Latest Developments 13.2 NeuroConn 13.2.1 NeuroConn Company Information 13.2.2 NeuroConn Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.2.3 NeuroConn Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 NeuroConn Main Business Overview 13.2.5 NeuroConn Latest Developments 13.3 Abbott 13.3.1 Abbott Company Information 13.3.2 Abbott Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.3.3 Abbott Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Abbott Main Business Overview 13.3.5 Abbott Latest Developments 13.4 Boston Scientific 13.4.1 Boston Scientific Company Information 13.4.2 Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.4.3 Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Boston Scientific Main Business Overview 13.4.5 Boston Scientific Latest Developments 13.5 Neuropace 13.5.1 Neuropace Company Information 13.5.2 Neuropace Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.5.3 Neuropace Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Neuropace Main Business Overview 13.5.5 Neuropace Latest Developments 13.6 Aleva Neurotherapeutics 13.6.1 Aleva Neurotherapeutics Company Information 13.6.2 Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.6.3 Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Aleva Neurotherapeutics Main Business Overview 13.6.5 Aleva Neurotherapeutics Latest Developments 13.7 Laborie 13.7.1 Laborie Company Information 13.7.2 Laborie Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.7.3 Laborie Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Laborie Main Business Overview 13.7.5 Laborie Latest Developments 13.8 Electrocore 13.8.1 Electrocore Company Information 13.8.2 Electrocore Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.8.3 Electrocore Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Electrocore Main Business Overview 13.8.5 Electrocore Latest Developments 13.9 Medtronic 13.9.1 Medtronic Company Information 13.9.2 Medtronic Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.9.3 Medtronic Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Medtronic Main Business Overview 13.9.5 Medtronic Latest Developments 13.10 Interaxon 13.10.1 Interaxon Company Information 13.10.2 Interaxon Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.10.3 Interaxon Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Interaxon Main Business Overview 13.10.5 Interaxon Latest Developments 13.11 Fisher Wallace 13.11.1 Fisher Wallace Company Information 13.11.2 Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.11.3 Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Fisher Wallace Main Business Overview 13.11.5 Fisher Wallace Latest Developments 13.12 Dreem 13.12.1 Dreem Company Information 13.12.2 Dreem Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.12.3 Dreem Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Dreem Main Business Overview 13.12.5 Dreem Latest Developments 13.13 SceneRay 13.13.1 SceneRay Company Information 13.13.2 SceneRay Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.13.3 SceneRay Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 SceneRay Main Business Overview 13.13.5 SceneRay Latest Developments 13.14 Pins Medical 13.14.1 Pins Medical Company Information 13.14.2 Pins Medical Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.14.3 Pins Medical Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Pins Medical Main Business Overview 13.14.5 Pins Medical Latest Developments 13.15 Spectris 13.15.1 Spectris Company Information 13.15.2 Spectris Alzheimer's Non-Pharmacological Treatment Device Product Portfolios and Specifications 13.15.3 Spectris Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 Spectris Main Business Overview 13.15.5 Spectris Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD（device）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
